The purpose of this study is to see if a specialized imaging technique using MRI called multi-exponential T2 component analysis can reliably differentiate between normal brain and brain tumour.
Existing methods of contouring tumours for radiation therapy involve manual interpretations of qualitative diagnostic images. These methods, being qualitative, do not offer a consistent and reproducible platform for contouring, making it difficult to evaluate the effects of contouring choices on treatment outcome. T2 component analysis in MRI has the potential to offer a quantitive basis for identifying tumor tissue- this potential is investigated in this pilot study.
Study Type
OBSERVATIONAL
Enrollment
20
Cross Cancer Institute
Edmonton, Alberta, Canada
RECRUITINGT2 characteristics of glioma tissue versus normal
Time frame: Before radiotherapy treatment begins
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.